About PharmOptima
PharmOptima is a Healthcare company based in Portage (United States) founded in 2003, and was acquired by Genesis Biotechnology Group in March 2017. ADME testing services in vivo and in vitro are provided. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include BioQual, ReveraGen and Headlands Research.
Company details
PharmOptima, acquired by Genesis Biotechnology Group, (a consortium of biotech and research companies) is a preclinical CRO offering in vivo and in vitro testing services and specializing in ocular drug development. Their services include ADME studies, PK and pharmacology testing, LC-MSMS bioanalysis, biomarker identification in disease models, cell based assay development, ELISA and electrochemiluminescence multiplex formats, protein cloning and expression, among several others.
- Headquarters Portage, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmoptima.com
- Social LinkedIn
- Acquired by Genesis Biotechnology Group (Mar 2017)
- Investors
- Acquired byGenesis Biotechnology Group
(Mar 2017)
Investors in PharmOptima
PharmOptima has secured backing from 1 investor. Prominent investors backing the company include Genesis Biotechnology Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A consortium of companies focused on improving patient care. | genesisbiotechgroup.com | Hamilton, United States |
Investor details for PharmOptima
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PharmOptima
2 people are tracked at PharmOptima (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Albert Schauer | CEO | Leadership |
Vicki Zaworski | Business Development Manager | Team |
Complete people profiles for PharmOptima
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PharmOptima
2 dated milestones of PharmOptima across 14 years, from founding to its latest funding, stage changes and deals.
- Founded PharmOptima is founded.
- Exit Acquired by Genesis Biotechnology Group.
Competitors of PharmOptima
PharmOptima has 3 listed competitors in our database. They include BioQual, ReveraGen and Headlands Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioqual.com | 1981 | Rockville, United States | 193 | Contract research on infectious disease models is conducted. | ||
| reveragen.com | 2008 | Rockville, United States | Steroids for Duchenne muscular dystrophy treatment are developed. | |||
| headlandsresearch.com | 2018 | San Francisco, United States | Clinical research services are provided by Headlands Research globally. |
Detailed competitors of PharmOptima
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PharmOptima
The website of PharmOptima (pharmoptima.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 27.1% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PharmOptima (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmoptima
Complete news archive for PharmOptima
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmOptima
PharmOptima was founded in 2003.
PharmOptima is headquartered in Portage, United States.
PharmOptima, acquired by Genesis Biotechnology Group, (a consortium of biotech and research companies) is a preclinical CRO offering in vivo and in vitro testing services and specializing in ocular drug development. Their services include ADME studies, PK and pharmacology testing, LC-MSMS bioanalysis, biomarker identification in disease models, cell based assay development, ELISA and electrochemiluminescence multiplex formats, protein cloning and expression, among several others.
PharmOptima's top competitors include BioQual, ReveraGen and Headlands Research.
PharmOptima has 1 investor. Key investors include Genesis Biotechnology Group.
Yes. PharmOptima was acquired by Genesis Biotechnology Group in March 2017.